DSM BioSolutions: (Bio-) Pharmaceuticals by microbial fermentation
By 2015, eight of the top 10-selling drugs will be a biopharmaceutical protein. A major part of these novel drugs can be produced most efficiently by microbial fermentation.
Meanwhile, also small molecule pharmaceuticals are receiving renewed interest in the treatment of e.g. resilient infectious diseases. Novel molecules often are produced by fermentation with follow-on chemical modification.
The future looks fermentation-based, and if you need a proven contract manufacturer to help capitalize on the wealth of emerging new opportunities ...look no further than DSM.
We have 100 years of experience in microbial fermentation, producing a variety of product classes. Our bright science comes from a proven blend of technologies, processes – and of course- people.
Whatever the project, capacity or timelines, we can help you get your product to clinic and market faster and more efficiently.Whatever the project, capacity or timescales, we can help you get your product to market fast and more efficiently.
DSM – repurchase of shares (29 November – 5 December 2013)
06 Dec 2013 09:15 CET
DSM partners with Union-Tech and AM Korea delivering innovative additive manufacturing to the area
04 Dec 2013 18:00 CET
Johns Hopkins Bloomberg School of Public Health awards Dean’s Medal to Royal DSM N.V.
04 Dec 2013 17:15 CET